ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.984,32
0,74%
S&P 500
5.966,19
-1,18%
Dow Jones
42.995,00
-0,76%
Euro vs US Dollar
1,04269
0,05%
Bitcoin
94.198,86
-1,55%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Pharvaris NV (PHVS)

  7. Pharvaris NV (PHVS) News

PHVS

Pharvaris NV (PHVS)

Pharvaris NV
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PHVS
DatumZeitQuelleÜberschriftSymbolFirma
02/12/202422h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
13/11/202422h12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
13/11/202422h10GlobeNewswire Inc.Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business UpdatesNASDAQ:PHVSPharvaris NV
12/11/202412h50GlobeNewswire Inc.Pharvaris to Participate in the Guggenheim Healthcare Innovation ConferenceNASDAQ:PHVSPharvaris NV
31/10/202421h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
24/10/202422h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
24/10/202414h00GlobeNewswire Inc.Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific MeetingNASDAQ:PHVSPharvaris NV
16/10/202412h50GlobeNewswire Inc.Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific MeetingsNASDAQ:PHVSPharvaris NV
15/10/202412h50GlobeNewswire Inc.Pharvaris to Host Virtual Investor Event on October 23, 2024NASDAQ:PHVSPharvaris NV
03/10/202412h50GlobeNewswire Inc.Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership WorkshopNASDAQ:PHVSPharvaris NV
25/09/202412h50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
23/09/202412h51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
20/09/202422h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
20/09/202400h45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
20/09/202400h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
19/09/202422h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
16/09/202422h46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
05/09/202412h51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
05/09/202412h50GlobeNewswire Inc.Pharvaris Provides Business Update and Expands Development Program for DeucrictibantNASDAQ:PHVSPharvaris NV
05/09/202412h49GlobeNewswire Inc.Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024NASDAQ:PHVSPharvaris NV
05/09/202412h48GlobeNewswire Inc.Pharvaris Presents Data at the Bradykinin Symposium 2024NASDAQ:PHVSPharvaris NV
28/08/202412h50GlobeNewswire Inc.Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin SymposiumNASDAQ:PHVSPharvaris NV
14/08/202412h51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
14/08/202412h50GlobeNewswire Inc.Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PHVSPharvaris NV
11/06/202412h52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
11/06/202412h50GlobeNewswire Inc.Pharvaris Announces Annual Meeting of ShareholdersNASDAQ:PHVSPharvaris NV
04/06/202422h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PHVSPharvaris NV
04/06/202412h50GlobeNewswire Inc.Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent CongressesNASDAQ:PHVSPharvaris NV
24/05/202423h04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
22/05/202423h54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PHVSPharvaris NV
 Showing the most relevant articles for your search:NASDAQ:PHVS

Kürzlich von Ihnen besucht

NYSE
GSL
Global Ship Lease
NASDAQ
PHVS
Pharvaris NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten